Please login to the form below

Not currently logged in
Email:
Password:

Pharma profit

This page shows the latest Pharma profit news and features for those working in and with pharma, biotech and healthcare.

Daily Brief: Azar blasts pharma, NICE forces MS drug prices down, Xenicos gets $30m funding

Daily Brief: Azar blasts pharma, NICE forces MS drug prices down, Xenicos gets $30m funding. ... I’ve been a drug company executive— I know the tired talking points: the idea that if one penny disappears from pharma profit margins, American

Latest news

  • Profit: the ugly, dirty truth? Profit: the ugly, dirty truth?

    There is no getting away from it. Outside Wall Street, profit is a sensitive and touchy subject for pharma companies. ... It seems easy to attack pharma companies for their profits, but no one should lose sight of the fact that profit is the fuel needed

  • Novartis telemedicine service to be ramped up in Ghana Novartis telemedicine service to be ramped up in Ghana

    The Foundation, a non-profit arm of the Swiss pharma firm, joins project partners that include Ericsson, Airtel and Columbia University. ... Digital inspiration for pharma on mobile, social media, strategy, best practice, regulations and more.

  • Hanover Health picks up a trio of new accounts Hanover Health picks up a trio of new accounts

    Andrew Harrison, managing director at Hanover Health, said: “We have intentionally sought to diversify our client-mix, ensuring we work with a broad spectrum of organisations - pharma, medical devices, ... profit and consumer health companies.

  • Pharma needs to 'better articulate' its value to society Pharma needs to 'better articulate' its value to society

    Pharma needs to 'better articulate' its value to society. And that includes its need to finance new medical discoveries by making a profit. ... Incentivising innovation. Also speaking at the event in Barcelona was Janssen's company group chairman Jane

  • GSK shelves ViiV sale as it lays out growth strategy GSK shelves ViiV sale as it lays out growth strategy

    GSK shelves ViiV sale as it lays out growth strategy. Firm now bullish on the HIV joint pharma project’ s prospects. ... First-quarter group sales came in at $5.6bn, with a 10% gain for vaccines and 24% hike for consumer health offsetting a 7% drop in

More from news
Approximately 1 fully matching, plus 39 partially matching documents found.

Latest Intelligence

  • Proving real-world value Proving real-world value

    This enables pharma companies to give trusts something they can roll-out themselves - and everyone benefits from the data. ... There’s a growing evidence-base that pharma can harness to drive better outcomes.

  • Don't you forget about me Don't you forget about me

    obviously an area of significant focus for pharma as they continue to introduce innovative therapies. ... When it comes to best practice, not-for-profit organisations are really showing the pharma world what support can and should look like.

  • Listen? Do you want to know a secret? Listen? Do you want to know a secret?

    With public trust in pharma perennially questioned, the industry cannot afford insinuations of eavesdropping in the pursuit of profit. ... It's a big opportunity. “ Pharma's key objective is to understand its customers.

  • Unravelling China’s healthcare sector Unravelling China’s healthcare sector

    However, leading companies are no longer satisfied with the increasing competition and diminishing profit margin. ... Jiangsu Hengrui Pharma and Hutchison Medi Pharma are running clinical trials in overseas regulated markets including the US .

  • An eye towards the biobetter in South Korea An eye towards the biobetter in South Korea

    This decreased profit margins of domestic pharma manufacturers by an average of 3.4 per cent. ... VM-505. Reyon Pharma / ViroMed. Fc-optimised HER2 mAb. S Korea. Preclinical as of Dec 2012.

More from intelligence
Approximately 0 fully matching, plus 6 partially matching documents found.

Latest appointments

  • New Merck Foundation appoints Rasha Kelej New Merck Foundation appoints Rasha Kelej

    New Merck Foundation appoints Rasha Kelej. She takes up role as CEO of the pharma firm's newly-established non-profit. ... Rasha Kelej has been appointed chief executive officer for Merck KGaA’s non-profit limited liability company, The Merck Foundation

More from appointments
Approximately 0 fully matching, plus 1 partially matching documents found.

Latest from PMHub

  • Don't you forget about me...

    obviously an area of significant focus for pharma as they continue to introduce innovative therapies. ... When it comes to best practice, not-for-profit organisations are really showing the pharma world what support can and should look like.

  • GOOD PHARMA — Better for patients, better for business

    GOOD PHARMA — Better for patients, better for business. Pharma is a dirty word to some. ... Indisputably, pharma companies are powered by profit, but so is any business.

  • HAVAS LYNX

    Today, smart pharma companies should be asking that same question about another major development: Connected Health. ... Indisputably, pharma companies are powered by profit, but so is any business.

More from PMHub
Approximately 0 fully matching, plus 3 partially matching documents found.

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Solaris Health

The beauty of detail: an effective, compelling medical communications campaign requires each component to be carefully planned, expertly crafted and...

Latest intelligence

Developing advocacy in the pharmaceutical industry.
The importance of advocacy programmes...
GDPR and events. What does the pharma industry need to know?
Many people in the pharma industry still aren’t following the rules set out by the GDPR when it comes to running events and attending tradeshows. But with eye-watering fines for...
Digital trends in B2B sales - how far behind is Pharma?
The modern approach to B2B sales is data-driven, and enabled by digital tools....

Infographics